CABIO(SH:688089) 证券时报·2025-08-30 05:11Core Viewpoint - The article discusses the termination of a significant asset restructuring by Jia Bi You (688089), highlighting the company's strategic decision-making in response to changing market conditions and its ongoing business performance [2][4]. Group 1: Termination of Asset Restructuring - Jia Bi You announced the termination of its plan to acquire a 63.21% stake in Ou Yi Biological, which was initially valued at approximately 831 million yuan [4]. - The decision to withdraw the application for the asset purchase and related funding was made after thorough communication with relevant parties, and it does not impose any breach of contract liabilities on the company [4][5]. - The company emphasized that the termination of this transaction will not adversely affect its daily operations or the interests of its shareholders, particularly minority shareholders [4][5]. Group 2: Business Performance - In the first half of the year, Jia Bi You reported a revenue of 307 million yuan, representing a year-on-year growth of 17.6%, and a net profit attributable to shareholders of 108 million yuan, reflecting a 59.01% increase [5]. - The demand for ARA and DHA products has been steadily increasing, driven by the gradual replacement of old national standard milk powder and the recovery of the maternal and infant consumption market due to birth subsidies [5]. - The concentration of leading milk powder brands in the industry has contributed significantly to the growth in sales of core customers [5].